T. Rowe Price Associates’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $26K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $120K | Hold |
|
|||||
|
2024
Q2 | $167K | Buy |
|
|||||
|
2024
Q1 | $174K | Sell |
|
|||||
|
2023
Q4 | $77K | Hold |
|
|||||
|
2023
Q3 | $59K | Buy |
|
|||||
|
2023
Q2 | $37K | Sell |
|
|||||
|
2023
Q1 | $104K | Buy |
|
|||||
|
2022
Q4 | $149K | Sell |
|
|||||
|
2022
Q3 | $207K | Sell |
|
|||||
|
2022
Q2 | $222K | Buy |
|
|||||
|
2022
Q1 | $451K | Buy |
|
|||||
|
2021
Q4 | $574K | Sell |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q2 | $1.44M | Buy |
|
|||||
|
2021
Q1 | $1.35M | Sell |
|
|||||
|
2020
Q4 | $1.39M | Buy |
|
|||||
|
2020
Q3 | $982K | Buy |
|
|||||
|
2020
Q2 | $1.69M | Buy |
|
|||||
|
2020
Q1 | $308K | Buy |
|
|||||
|
2019
Q4 | $61K | Buy |
|
|||||
|
2019
Q3 | $30K | Buy |
|
|||||
|
2019
Q2 | $40K | Hold |
|
|||||
|
2019
Q1 | $51K | Buy |
|
|||||
|
2018
Q4 | $54K | Buy |
|
|||||
|
2018
Q3 | $75K | Buy |
|
|||||
|
2018
Q2 | $51K | Buy |
|
|||||
|
2018
Q1 | $61K | Buy |
|
|||||
|
2017
Q4 | $42K | Hold |
|
|||||
|
2017
Q3 | $65K | Hold |
|
|||||
|
2017
Q2 | $80K | Hold |
|
|||||
|
2017
Q1 | $68K | Buy |
|